A model of infection and immune response to low dose radiation

References

• Ali N. 2020. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol. 92(11):2409–2411.
   PubMed Web of Science ®Google Scholar
• Ameri A, Ameri P, Rahnama N, Mokhtari M, Sedaghat M, Hadavand F, Bozorgmehr R, Haghighi M, Taghizadeh-Hesary F. 2020. Low-dose whole-lung irradiation for COVID-19 pneumonia: final results of a pilot study. Int J Radiat Oncol Biol Phys. 109(4):859–866.
   PubMed Web of Science ®Google Scholar
• Arenas M, Algara M, De Febrer G, Rubio C, Sanz X, de la Casa MA, Vasco C, Marin J, Fernandez-Leton P, Villar J, et al. 2021. Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial). Strahlenther Onkol. 197(11):1010–1020.
   PubMed Web of Science ®Google Scholar
• Arenas M, Gil F, Gironella M, Hernandez V, Biete A, Pique JM, Panes J. 2008. Time course of anti-inflammatory effect of low-dose radiotherapy: correlation with TGF-beta(1) expression. Radiother Oncol. 86(3):399–406.
   PubMed Web of Science ®Google Scholar
• Arenas M, Sabater S, Hernandez V, Rovirosa A, Lara PC, Biete A, Panes J. 2012. Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved. Strahlenther Onkol. 188(11):975–981.
   PubMed Web of Science ®Google Scholar
• Armstrong RA, Kane AD, Kursumovic E, Oglesby FC, Cook TM. 2021. Mortality in patients admitted to intensive care with COVID-19: an updated systematic review and meta-analysis of observational studies. Anaesthesia. 76(4):537–548.
   PubMed Web of Science ®Google Scholar
• Attaway AH, Scheraga RG, Bhimraj A, Biehl M, Hatipoğlu U. 2021. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ. 372:n436.
   PubMedGoogle Scholar
• Baccam P, Beauchemin C, Macken CA, Hayden FG, Perelson AS. 2006. Kinetics of influenza A virus infection in humans. J Virol. 80(15):7590–7599.
   PubMed Web of Science ®Google Scholar
• Bar-On YM, Flamholz A, Phillips R, Milo R. 2020. SARS-CoV-2 (COVID-19) by the numbers. Elife. 9:e57309.
   PubMed Web of Science ®Google Scholar
• Bhagat S, Yadav N, Shah J, Dave H, Swaraj S, Tripathi S, Singh S. 2020. Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease. Expert Rev anti Infect Ther. 1–24. DOI:https://doi.org/10.1080/14787210.2021.1835469.
   Google Scholar
• Calabrese EJ, Dhawan G, Kapoor R, Kozumbo WJ. 2019. Radiotherapy treatment of human inflammatory diseases and conditions: optimal dose. Hum Exp Toxicol. 38(8):888–898.
   PubMed Web of Science ®Google Scholar
• Calabrese EJ, Kozumbo WJ, Kapoor R, Dhawan G, Lara PC, Giordano J. 2021. Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): novel mechanistic considerations. Radiother Oncol. 160:125–131.
   PubMed Web of Science ®Google Scholar
• Chaudhary R, Garg J, Houghton DE, Murad MH, Kondur A, Chaudhary R, Wysokinski WE, McBane RD 2nd. 2021. Thromboinflammatory biomarkers in COVID-19: systematic review and meta-analysis of 17,052 patients. Mayo Clin Proc Innov Qual Outcomes. 5(2):388–402.
   PubMedGoogle Scholar
• Chen F, Hao L, Zhu S, Yang X, Shi W, Zheng K, Wang T, Chen H. 2021. Potential adverse effects of dexamethasone therapy on COVID-19 patients: review and recommendations. Infect Dis Ther. 10(4):1907–1931.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, Men D, Huang Q, Liu Y, Yang B, et al. 2020. Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis. 71(8):1937–1942.
   PubMed Web of Science ®Google Scholar
• Chomarat P, Banchereau J, Davoust J, Palucka AK. 2000. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol. 1(6):510–514.
   PubMed Web of Science ®Google Scholar
• Chun SH, Park GY, Han YK, Kim SD, Kim JS, Lee CG, Yang K. 2012. Effect of low dose radiation on differentiation of bone marrow cells into dendritic cells. Dose Response. 11(3):374–384.
   PubMed Web of Science ®Google Scholar
• Del Castillo R, Martinez D, Sarria GJ, Pinillos L, Garcia B, Castillo L, Carhuactocto A, Giordano FA, Sarria GR. 2020. Low-dose radiotherapy for COVID-19 pneumonia treatment: case report, procedure, and literature review. Strahlenther Onkol. 196(12):1086–1093.
   PubMed Web of Science ®Google Scholar
• Dhawan G, Kapoor R, Dhawan R, Singh R, Monga B, Giordano J, Calabrese EJ. 2020. Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS). Radiother Oncol. 147:212–216.
   PubMed Web of Science ®Google Scholar
• Faes C, Abrams S, Van Beckhoven D, Meyfroidt G, Vlieghe E, Hens N, Belgian Collaborative Group on C-HS. 2020. Time between Symptom onset, hospitalisation and recovery or death: statistical analysis of Belgian COVID-19 patients. Int J Environ Res Public Health. 17(20):7560.
   Web of Science ®Google Scholar
• Fakih MG, Ottenbacher A, Yehia B, Fogel R, Miller C, Winegar A, Jesser C, Cacchione J. 2022. COVID-19 hospital prevalence as a risk factor for mortality: an observational study of a multistate cohort of 62 hospitals. BMJ Qual Saf. 31(1):45–53.
   PubMed Web of Science ®Google Scholar
• Finelli L, Gupta V, Petigara T, Yu K, Bauer KA, Puzniak LA. 2021. Mortality among US patients hospitalized with SARS-CoV-2 infection in 2020. JAMA Netw Open. 4(4):e216556.
   PubMed Web of Science ®Google Scholar
• Frischholz B, Wunderlich R, Ruhle PF, Schorn C, Rodel F, Keilholz L, Fietkau R, Gaipl US, Frey B. 2013. Reduced secretion of the inflammatory cytokine IL-1β by stimulated peritoneal macrophages of radiosensitive Balb/c mice after exposure to 0.5 or 0.7 Gy of ionizing radiation. Autoimmunity. 46(5):323–328.
   PubMed Web of Science ®Google Scholar
• Ganesan G, Ponniah S, Sundaram V, Marimuthu PK, Pitchaikannu V, Chandrasekaran M, Thangarasu J, Kannupaiyan G, Ramamoorthy P, Thangaraj B, et al. 2021. Whole lung irradiation as a novel treatment for COVID-19: interim results of an ongoing phase 2 trial in India. Radiother Oncol. 163:83–90.
   PubMed Web of Science ®Google Scholar
• Garcia-Hernandez T, Romero-Exposito M, Sanchez-Nieto B. 2020. Low dose radiation therapy for COVID-19: effective dose and estimation of cancer risk. Radiother Oncol. 153:289–295.
   PubMed Web of Science ®Google Scholar
• Goncalves A, Bertrand J, Ke RA, Comets E, de Lamballerie X, Malvy D, Pizzorno A, Terrier O, Calatrava MR, Mentre F, et al. 2020. Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load. CPT Pharmacometrics Syst Pharmacol. 9(9):509–514.
   PubMedGoogle Scholar
• Gong J, Dong H, Xia QS, Huang ZY, Wang DK, Zhao Y, Liu WH, Tu SH, Zhang MM, Wang Q, et al. 2020. Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study. BMC Infect Dis. 20(1):963.
   PubMed Web of Science ®Google Scholar
• Guan J, Wei X, Qin S, Liu X, Jiang Y, Chen Y, Chen Y, Lu H, Qian J, Wang Z, et al. 2020. Continuous tracking of COVID-19 patients' immune status. Int Immunopharmacol. 89(Pt A):107034.
   PubMedGoogle Scholar
• Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, China Medical Treatment Expert Group for Covid-19, et al. 2020. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Hanna CR, Robb KA, Blyth KG, Jones RJ, Chalmers AJ. 2021. Clinician attitudes to using low-dose radiation therapy to treat COVID-19 lung disease. Int J Radiat Oncol Biol Phys. 109(4):886–890.
   PubMed Web of Science ®Google Scholar
• He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, Lau YC, Wong JY, Guan Y, Tan X, et al. 2020a. Author correction: temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 26(9):1491–1493.
   PubMed Web of Science ®Google Scholar
• He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, Lau YC, Wong JY, Guan Y, Tan X, et al. 2020b. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 26(5):672–675.
   PubMed Web of Science ®Google Scholar
• Hess CB, Eng TY, Nasti TH, Dhere VR, Kleber TJ, Switchenko JM, Weinberg BD, Rouphael N, Tian S, Rudra S, et al. 2021. Whole-lung low-dose radiation therapy (LD-RT) for non-intubated oxygen-dependent patients with COVID-19-related pneumonia receiving dexamethasone and/or remdesevir. Radiother Oncol. 165:20–31.
   PubMed Web of Science ®Google Scholar
• Hess CB, Nasti TH, Dhere V, Kleber T, Switchenko JM, Buchwald ZS, Stokes W, Weinberg BD, Rouphael N, Steinberg JP, et al. 2020. Immunomodulatory low-dose whole-lung radiation for patients with COVID-19-related pneumonia. Int J Radiat Oncol Biol Phys. 108(5):1401.
   Web of Science ®Google Scholar
• Jang S, Rhee JY, Wi YM, Jung BK. 2021. Viral kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period. Int J Infect Dis. 102:561–565.
   PubMed Web of Science ®Google Scholar
• Kapoor R, Welsh JS, Dhawan V, Javadinia SA, Calabrese EJ, Dhawan G. 2021. Low-dose radiation therapy (LDRT) for COVID-19 and its deadlier variants. Arch Toxicol. 95(10):3425–3432.
   PubMed Web of Science ®Google Scholar
• Katzenschlager S, Zimmer AJ, Gottschalk C, Grafeneder J, Schmitz S, Kraker S, Ganslmeier M, Muth A, Seitel A, Maier-Hein L, et al. 2021. Can we predict the severe course of COVID-19 – a systematic review and meta-analysis of indicators of clinical outcome? PLOS One. 16(7):e0255154.
   PubMed Web of Science ®Google Scholar
• Khan MK, Hess CB. 2021. A call to action: “low-dose radiation may help cure COVID-19…” [Taps Mic] “…is this thing on?” JNCI Cancer Spectr. 5(1):105.
   Web of Science ®Google Scholar
• Kirkby C, Mackenzie M. 2020. Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? Radiother Oncol. 147:221.
   PubMed Web of Science ®Google Scholar
• Kooistra EJ, van Berkel M, van Kempen NF, van Latum CRM, Bruse N, Frenzel T, van den Berg MJW, Schouten JA, Kox M, Pickkers P. 2021. Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients. Crit Care. 25(1):281.
   PubMed Web of Science ®Google Scholar
• Lakka TA, Lakka HM, Rankinen T, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C. 2005. Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study. Eur Heart J. 26(19):2018–2025.
   PubMed Web of Science ®Google Scholar
• Lara PC, Burgos J, Macias D. 2020. Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment. Clin Transl Radiat Oncol. 23:27–29.
   PubMed Web of Science ®Google Scholar
• Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. 2020. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 172(9):577–582.
   PubMed Web of Science ®Google Scholar
• Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, et al. 2020. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 20(6):697–706.
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al. 2020. Early transmission dynamics in Wuhan, China, of Novel coronavirus-infected pneumonia. N Engl J Med. 382(13):1199–1207.
   PubMed Web of Science ®Google Scholar
• Li SH, Jiang L, Li X, Lin F, Wang YJ, Li BA, Jiang TJ, An WM, Liu SH, Liu HY, et al. 2020. Clinical and pathological investigation of patients with severe COVID-19. JCI Insight. 5(12):e138070.
   PubMed Web of Science ®Google Scholar
• Li YC, Li J, Ke J, Jiao N, Zhu LX, Shen LH, Chen L, Jiang ZQ, Cheng SJ, Huang YB, et al. 2021. Adverse outcomes associated with corticosteroid use in critical COVID-19: a retrospective multicenter cohort study. Front Med-Lausanne. 8:604263.
   PubMed Web of Science ®Google Scholar
• Ling Y, Xu SB, Lin YX, Tian D, Zhu ZQ, Dai FH, Wu F, Song ZG, Huang W, Chen J, et al. 2020. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J. 133(9):1039–1043.
   PubMed Web of Science ®Google Scholar
• Liu J, Li S, Liu J, Liang B, Wang X, Wang H, Li W, Tong Q, Yi J, Zhao L, et al. 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 55:102763.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang S, Dong X, Li Z, Xu Q, Feng H, Cai J, Huang S, Guo J, Zhang L, et al. 2020. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome. J Clin Invest. 130(12):6417–6428.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang C, Huang F, Yang Y, Wang F, Yuan J, Zhang Z, Qin Y, Li X, Zhao D, et al. 2020. Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury. Natl Sci Rev. 7(6):1003–1011.
   PubMed Web of Science ®Google Scholar
• Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M, Gabrilove JL, Sacks H. 2021. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Ebm. 26(3):107–108.
   Google Scholar
• Mariotti LG, Bertolotti A, Ranza E, Babini G, Ottolenghi A. 2012. Investigation of the mechanisms underpinning IL-6 cytokine release in bystander responses: the roles of radiation dose, radiation quality and specific ROS/RNS scavengers. Int J Radiat Biol. 88(10):751–762.
   PubMed Web of Science ®Google Scholar
• Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, El Naqa I, Hubbs JL, Lebesque JV, Timmerman RD, et al. 2010. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys. 76(3 Suppl):S70–S76.
   PubMed Web of Science ®Google Scholar
• Melo AKG, Milby KM, Caparroz A, Pinto A, Santos RRP, Rocha AP, Ferreira GA, Souza VA, Valadares LDA, Vieira R, et al. 2021. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: a living systematic review and meta-analysis. PLOS One. 16(6):e0253894.
   PubMed Web of Science ®Google Scholar
• Meziani L, Robert C, Classe M, Da Costa B, Mondini M, Clemenson C, Alfaro A, Mordant P, Ammari S, Le Goffic R, et al. 2021. Low doses of radiation increase the immunosuppressive profile of lung macrophages during viral infection and pneumonia. Int J Radiat Oncol Biol Phys. 110(5):1283–1294.
   PubMed Web of Science ®Google Scholar
• Moreno-Olmedo E, Suarez-Gironzini V, Perez M, Filigheddu T, Minguez C, Sanjuan-Sanjuan A, Gonzalez JA, Rivas D, Gorospe L, Larrea L, et al. 2021. COVID-19 pneumonia treated with ultra-low doses of radiotherapy (ULTRA-COVID study): a single institution report of two cases. Strahlenther Onkol. 197(5):429–437.
   PubMed Web of Science ®Google Scholar
• Mousavi Darzikolaee N, Kolahdouzan K, Abtahi H, Kazemizadeh H, Salehi M, Ghalehtaki R, Bayani R, Pestehei SK, Ghazanfari T, Ebrahiminasab F, et al. 2021. Low-dose whole-lung irradiation in severe COVID-19 pneumonia: a controlled clinical trial. J Med Radiat Sci. 68(4):396–406.
   PubMed Web of Science ®Google Scholar
• Mueller AA, Tamura T, Crowley CP, DeGrado JR, Haider H, Jezmir JL, Keras G, Penn EH, Massaro AF, Kim EY. 2020. Inflammatory biomarker trends predict respiratory decline in COVID-19 patients. Cell Rep Med. 1(8):100144.
   PubMedGoogle Scholar
• Nakatsukasa H, Tsukimoto M, Ohshima Y, Tago F, Masada A, Kojima S. 2008. Suppressing effect of low-dose gamma-ray irradiation on collagen-induced arthritis. J Radiat Res. 49(4):381–389.
   PubMed Web of Science ®Google Scholar
• Neant N, Lingas G, Le Hingrat Q, Ghosn J, Engelmann I, Lepiller Q, Gaymard A, Ferre V, Hartard C, Plantier JC, et al. 2021. Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort. Proc Natl Acad Sci USA. 118(8):e2017962118.
   PubMed Web of Science ®Google Scholar
• Noreen S, Maqbool I, Madni A. 2021. Dexamethasone: therapeutic potential, risks, and future projection during COVID-19 pandemic. Eur J Pharmacol. 894:173854.
   PubMed Web of Science ®Google Scholar
• Papachristofilou A, Finazzi T, Blum A, Zehnder T, Zellweger N, Lustenberger J, Bauer T, Dott C, Avcu Y, Kohler G, et al. 2021. Low dose radiation therapy for severe COVID-19 pneumonia: a randomized double-blind study. Int J Radiat Oncol Biol Phys. 110(5):1274–1282.
   PubMed Web of Science ®Google Scholar
• Prasanna PG, Woloschak GE, DiCarlo AL, Buchsbaum JC, Schaue D, Chakravarti A, Cucinotta FA, Formenti SC, Guha C, Hu DJ, et al. 2020. Low-dose radiation therapy (LDRT) for COVID-19: benefits or risks? Radiat Res. 194(5):452–464.
   PubMed Web of Science ®Google Scholar
• Pujadas E, Chaudhry F, McBride R, Richter F, Zhao S, Wajnberg A, Nadkarni G, Glicksberg BS, Houldsworth J, Cordon-Cardo C. 2020. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med. 8(9):e70.
   PubMed Web of Science ®Google Scholar
• Rana MA, Hashmi M, Qayyum A, Pervaiz R, Saleem M, Munir MF, Ullah Saif MM. 2020. Comparison of efficacy of dexamethasone and methylprednisolone in improving PaO2/FiO2 ratio among COVID-19 patients. Cureus. 12(10):e10918.
   PubMed Web of Science ®Google Scholar
• Recovery Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, et al. 2021. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 384(8):693–704.
   PubMed Web of Science ®Google Scholar
• Recovery Collaborative Group, Horby P, Mafham M, Peto R, Campbell M, Pessoa-Amorim G, Spata E, Staplin N, Emberson JR, Prudon B, et al. 2021. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. MedRxiv (preprint). DOI:https://doi.org/10.1101/2021.06.15.21258542.
   Google Scholar
• Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, Ca BP, Group CW, Jombart T, Procter SR, Knight GM. 2020. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 18(1):270.
   PubMed Web of Science ®Google Scholar
• Rodel F, Frey B, Gaipl U, Keilholz L, Fournier C, Manda K, Schollnberger H, Hildebrandt G, Rodel C. 2012. Modulation of inflammatory immune reactions by low-dose ionizing radiation: molecular mechanisms and clinical application. Curr Med Chem. 19(12):1741–1750.
   PubMed Web of Science ®Google Scholar
• Rodel F, Keilholz L, Kern P, Herrmann M, Beuscher HU, Sauer R. 2000. Effect of low dose radiation on adhesion and apoptosis-discontinuous cytokine expression as one possible mechanism of action. Int J Radiat Oncol Biol Phys. 48(3):283.
   Google Scholar
• Sanmamed N, Alcantara P, Cerezo E, Gaztañaga M, Cabello N, Gómez S, Bustos A, Doval A, Corona J, Rodriguez G, et al. 2021. Low-dose radiation therapy in the management of coronavirus disease 2019 (COVID-19) pneumonia (LOWRAD-Cov19): preliminary report. Int J Radiat Oncol Biol Phys. 109(4):880–885.
   PubMed Web of Science ®Google Scholar
• Sharifpour M, Rangaraju S, Liu M, Alabyad D, Nahab FB, Creel-Bulos CM, Jabaley CS, Emory C-Q, Clinical Research C, on behalf of the Emory COVID-19 Quality & Clinical Research Collaborative 2020. C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19. PLOS One. 15(11):e0242400.
   PubMed Web of Science ®Google Scholar
• Sharma DN, Guleria R, Wig N, Mohan AGK, Subramani V, Bhatnagar SS, Sharma APP, Madan K, Soneja MS, Singh AR, Singh S. 2020. Low dose radiation therapy for COVID-19 pneumonia: a pilot study. medRxiv (preprint). DOI:https://doi.org/10.1101/2020.11.16.20231514.
   Google Scholar
• Singh S, Khera D, Chugh A, Khera PS, Chugh VK. 2021. Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis. BMJ Open. 11(6):e048416.
   PubMed Web of Science ®Google Scholar
• Sun J, Tang X, Bai R, Liang C, Zeng L, Lin H, Yuan R, Zhou P, Huang X, Xiong Q, et al. 2020. The kinetics of viral load and antibodies to SARS-CoV-2. Clin Microbiol Infect. 26(12):1690 e1691–1690 e1694.
   Web of Science ®Google Scholar
• Szakmany T, Tuckwell W, Harte E, Wetherall N, Ramachandran S, Price S, Breen H, Killick C, Cheema Y, King C, et al. 2021. Differences in inflammatory marker kinetics between the first and second wave of COVID-19 patients admitted to the ICU: a retrospective, single-center study. J Clin Med. 10(15):3290.
   PubMed Web of Science ®Google Scholar
• Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. 2020. Cytokine Storm in COVID-19: the current evidence and treatment strategies. Front Immunol. 11:1708.
   PubMed Web of Science ®Google Scholar
• To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, Yip CC, Cai JP, Chan JM, Chik TS, et al. 2020. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 20(5):565–574.
   PubMed Web of Science ®Google Scholar
• Tsukimoto M, Homma T, Mutou Y, Kojima S. 2009. 0.5 Gy gamma radiation suppresses production of TNF-alpha through up-regulation of MKP-1 in mouse macrophage RAW264.7 cells. Radiat Res. 171(2):219–224.
   PubMed Web of Science ®Google Scholar
• V'Kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. 2021. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 19(3):155–170.
   PubMed Web of Science ®Google Scholar
• Walsh KA, Jordan K, Clyne B, Rohde D, Drummond L, Byrne P, Ahern S, Carty PG, O'Brien KK, O'Murchu E, et al. 2020. SARS-CoV-2 detection, viral load and infectivity over the course of an infection. J Infect. 81(3):357–371.
   PubMed Web of Science ®Google Scholar
• Wang S, Pan Y, Wang Q, Miao H, Brown AN, Rong L. 2020. Modeling the viral dynamics of SARS-CoV-2 infection. Math Biosci. 328:108438.
   PubMed Web of Science ®Google Scholar
• Westblade LF, Brar G, Pinheiro LC, Paidoussis D, Rajan M, Martin P, Goyal P, Sepulveda JL, Zhang L, George G, et al. 2020. SARS-CoV-2 viral load predicts mortality in patients with and without cancer who are hospitalized with COVID-19. Cancer Cell. 38(5):661–671.
   PubMed Web of Science ®Google Scholar
• WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo A-M, Preziosi M-P, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hernández García C, Kieny MP, et al. 2021. Repurposed antiviral drugs for Covid-19 – interim WHO solidarity trial results. N Engl J Med. 384(6):497–511.
   PubMed Web of Science ®Google Scholar
• Wunderlich R, Ernst A, Rodel F, Fietkau R, Ott O, Lauber K, Frey B, Gaipl US. 2015. Low and moderate doses of ionizing radiation up to 2 Gy modulate transmigration and chemotaxis of activated macrophages, provoke an anti-inflammatory cytokine milieu, but do not impact upon viability and phagocytic function. Clin Exp Immunol. 179(1):50–61.
   PubMed Web of Science ®Google Scholar
• Yuan J, Zou RR, Zeng LJ, Kou SL, Lan JF, Li XH, Liang YH, Ding XY, Tan GY, Tang SH, et al. 2020. The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients. Inflamm Res. 69(6):599–606.
   PubMed Web of Science ®Google Scholar
• Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q, Xie G, Lin S, Wang R, Yang X, et al. 2020. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 369:m1443.
   PubMed Web of Science ®Google Scholar